e-learning
resources
Munich 2014
Sunday, 07.09.2014
Biomarkers of asthma and clinical immunology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Case presentation: Should we always treat IgG4-related lung disease?
E. Baltaxe, T. Shulimzon, A. Onn, M. J. Segel (Ramat Gan, Tel Aviv, Israel)
Source:
International Congress 2014 – Biomarkers of asthma and clinical immunology
Session:
Biomarkers of asthma and clinical immunology
Session type:
Thematic Poster Session
Number:
1038
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Baltaxe, T. Shulimzon, A. Onn, M. J. Segel (Ramat Gan, Tel Aviv, Israel). Case presentation: Should we always treat IgG4-related lung disease?. Eur Respir J 2014; 44: Suppl. 58, 1038
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014
Pulmonary manifestations in adult patients with chronic granulomatous disease
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
Non- cystic fibrosis bronchiectasis in primary antibody deficiency patients
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
A case series of eight patients treated with alectinib including a case of interstitial lung disease
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016
Hughes-Stovin syndrome: A case report
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Liposomal local therapy of upper respiratory tract involvement in ANCA associated vasculitis
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Interstitial lung disease caused by filamin A gene mutations: Clinical course of three paediatric cases
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Genetic analysis of ethnicity of sarcoidosis patients in the Netherlands
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Childhood interstitial lung disease: A diagnostic challenge
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Pulmonary manifestation of X-linked agammaglobulinemia
Source: International Congress 2014 – Respiratory infections in children
Year: 2014
Family history of pneumothorax leading to Birt-Hogg-Dubé syndrome diagnosis
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Existence of “IgG4-related pleuritis” and its clinical features
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Clinical features and prognosis of 108 patients with lymphangioleiomyomatosis
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used
Source: International Congress 2017 – Rare diseases
Year: 2017
Videothoracoscopy in the differential diagnosis disseminated pulmonary diseases
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
Source: International Congress 2014 – ILDs 2
Year: 2014
Sarcoidosis in the UK: Insights from the BTS interstitial lung disease registry
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Miliary disease of the lung: What is your diagnosis?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept